• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EBO
Click for more information
0.90% $37.25

Ebos Group Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Healthcare

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EBO
Ann: Ongoing Disclosure Notices 		20/09/24 0 33
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  33 
EBO
Ann: Notice of Annual Meeting and Proxy Form 		20/09/24 0 27
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  27 
EBO
Ann: Capital Change Notice - DRP shares 		18/09/24 0 36
18/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  36 
EBO
Ann: Capital Change Notice - Employee Share Plan 		16/09/24 0 49
16/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  49 
EBO
Ann: DRP Strike Price 		12/09/24 0 54
12/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  54 
EBO
Ann: Performance Rights Update 		10/09/24 0 36
10/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  36 
EBO
Ann: Capital Change Notice - Performance Rights 		05/09/24 0 65
05/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  65 
EBO
Ann: Ongoing Disclosure Notices 		30/08/24 0 102
30/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  102 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
(20min delay)
Last
$37.25 		Change
-0.340(0.90%) 		Mkt cap ! n/a
Open High Low Value Volume
$37.50 $37.92 $37.16 $20.53M 549.5K

Buyers (Bids)

No. Vol. Price($)
0 600 $37.21
 

Sellers (Offers)

Price($) Vol. No.
$37.80 1329 0
Last trade - 12.59pm 20/09/2024 (20 minute delay) ?
EBO (NZSX) Chart

Top Stories

Harvey Norman hit with a second class action – and shareholders, once again, don't care

Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.